Skip to main content
ReadyRule homepageReadyRule

Inspection visit

Follow-up on corrections

MARBELLA VISALIALicense 5472008442 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

On 11/20/25, Licensing Program Analyst (LPA) Yang arrived unannounced conduct a Case Management deficiency visit. LPA introduce self, stated the purpose of the visit, and met with Resident Care Director Brittney Polman. The purpose of the today's visit is to address an incident where medications were found in the resident’s room after medication signed off by staff that medications were administered. Interviews were conducted, medications were checked, and records were received. R1’s evening medication Atorvastatin was founded in R1’s room the following day after the medication was signed off that it was administered. A deficiency is being cited, per California Code of Regulations, Title 22, Division 6, see attached Lic 809D. An exit interview was conducted. A copy of this report and appeal rights were provided to Resident Care Director, whose signature confirmed receipt of report.

Citations

2 citations recorded*CCLD

What does Type A vs Type B mean?

Type A. Serious citation. Imminent or substantial risk to children. The regulator requires corrective action immediately and may impose a civil penalty.

Type B. Lower-severity citation. Corrective action required, no imminent risk. The regulator monitors compliance on the next visit.

  • 87211(a)(1)Type B

    87211(a)(1) A written report shall be submitted to the licensing agency and to the person responsible for the resident within seven days of the occurrence of any of the events specified in (A) through (D) below. This report shall include the resident's name, age, sex and date of admission; date and nature of event; attending physician's name, findings, and treatment, if any; and disposition of the case.This requirement was not met as evidenced by: Based on record review and interview conducted, a written report was not reported to the department within 7 days of incident when R1’s Atorvastatin medication tablet was found the following day after medication was recorded administered, this poses a potential health and safety risk to residents in care.

  • 87411(d)(4)Type A

    87411(d)(4) Knowledge required to safely assist with prescribed medications which are self-administered.This requirement was not met as evidenced by: Based on observation, records reviewed, and interview conducted, R1 was given evening medication Atorvastatin and staff recorded that medication was administered. Atorvastatin medication tablet was found the following day. S1 did not ensure R1’s evening medication was administered as prescribed prior to recording that medication was administered, which poses/posed an immediate health and safety risk for the person in care.

FAQ · About this visit

Common questions about this visit

What happened during the November 20, 2025 inspection of MARBELLA VISALIA?

This was a other inspection of MARBELLA VISALIA on November 20, 2025. 2 citations were issued: 1 Type A (serious) and 1 Type B.

Were any citations issued to MARBELLA VISALIA on November 20, 2025?

Yes, 2 citations were issued (1 Type A, 1 Type B). The first citation was for: "87211(a)(1) A written report shall be submitted to the licensing agency and to the person responsible for the resident w..."

What type of inspection was this?

This was a other inspection. other inspections are conducted by CCLD as part of their licensing oversight.

SourceView on CCLDView original report

Share this reportEmail

Next steps

If this is your facility,claim this pageand correct anything the record gets wrong. Free.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CCLD public records. Last updated . If you believe any information is inaccurate, report it here.